News und Analysen
Clarification: The Grandpuits Conversion into a Zero-Crude Platform Continues and TotalEnergies will Meet All Its Commitments
The ongoing conversion of the Grandpuits refinery is entering a key phase. Over 1,200 people are working on the project, which includes the launch of an advanced plastics recycling unit, the first
Poxel Announces Grant of New Patent in Japan for the Use of Imeglimin in Type-2 Diabetic Patients with Renal Impairment
Regulatory News:
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Sensorion Announces Webconference, in French, for its Retail Shareholders on April 7, 2025
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss
Norway: TotalEnergies and Partners Launch the 2nd phase of Northern Lights CCS Project
TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) and its partners, Equinor and Shell, announce the Final Investment Decision (FID) of the second phase of the Northern Lights development, which will
TotalEnergies Publishes its Sustainability & Climate 2025 Progress Report and Further Strengthens Its Emissions Reduction Targets
TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) publishes today its Sustainability & Climate - 2025 Progress Report, which presents the progress of its transition strategy. This report completes the
PULLUP ENTERTAINMENT: DOTEMU, a subsidiary of PULLUP Entertainment, announces the release of “MARVEL Cosmic Invasion” in 2025
Medidata Launches the Site Insights Program to Elevate the Site Voice for Trials
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that it has introduced its Medidata Site Insights Program, a
EQS-News: Abivax publishes financial reports with the French and U.S. securities regulatory agencies
Correction of a release from 26.03.2025 17:37 CET/CEST - BILENDI: Record results in 2024
Mozambique LNG: TotalEnergies Welcomes the Launch of Official Investigations in Mozambique
Following allegations of human rights abuses raised by media outlets in 2024 that would have been committed by members of Mozambique’s Defence and Security Forces in the Afungi Peninsula in the
Germany: TotalEnergies Pursues Growth in Electricity by Launching Six New Battery Storage Projects
On the occasion of Patrick Pouyanné’s participation in the Europe 2025 conference in Berlin, and in connection with the Company’s integrated development in the country’s electricity sector
Sensorion Announces its Participation at the Van Lanschot Kempen Conference Life Sciences
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing
Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
TotalEnergies SE: Convening of the Annual Shareholders’ Meeting on May 23, 2025
The Board of Directors of TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) met on March 19, 2025 under the chairmanship of Mr. Patrick Pouyanné, Chairman and Chief Executive Officer. It has
EQS-News: Abivax Announces Full Year 2024 Financial Results
Poxel Announces Positive Results from a Preclinical Study for PXL065, a Proprietary Deuterium-Stabilized R-Stereoisomer of Pioglitazone, in Hypertrophic Cardiomyopathy
Regulatory News:
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Verimatrix führt XTD Velocity Partner Alliance ein, um den weltweiten Vertrieb über Kanäle zu beschleunigen
Regulatorische Nachrichten:
Verimatrix (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute den Start der Verimatrix XTD Velocity Partner
GenSight Biologics Confirms Definitive Full-Year 2024 Consolidated Financial Results Are in Line with Estimates
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
Verimatrix Launches XTD Velocity Partner Alliance to Accelerate Global Channel Sales
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the launch of the Verimatrix XTD Velocity
Dassault Systèmes Intensifies the MEDIDATA Commitment to Patient Experience With Investment in Click Therapeutics for Digital Therapeutics Beyond Clinical Trials
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its investment in Click Therapeutics, a leader in prescription digital therapeutics and software-enhanced drug therapies
New AR Experience from Dassault Systèmes Transforms Parisian Monuments with Sustainable Energy Innovations
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced “Energy Experience,” its immersive augmented reality experience that transforms Parisian monuments by showcasing sustainable
GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2025
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal
Sensorion Reports Full-Year 2024 Results, Provides Corporate Update and Announces Availability of Full-Year Report
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss